TransCode Therapeutics (RNAZ) Insider Trading & Ownership

→ Biden’s $374B Giveaway Into This Sector (From DTI) (Ad)

$0.50

0.00 (0.00%)

(As of 04/18/2024 ET)

Current Insider Ownership Percentage: 1.47%
Number Of Insiders Buying (Last 12 Months): 2
Amount Of Insider Buying (Last 12 Months): $144,403.20
Number Of Insiders Selling (Last 12 Months): 0

Get RNAZ Insider Trade Alerts

Want to know when executives and insiders are buying or selling TransCode Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

RNAZ Insider Buying and Selling by Quarter

Ad DTI

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

Click here for the full story

TransCode Therapeutics Insider and Congressional Trades History

Transaction Type

Time Frame

Start Date

End Date

Export to Excel

Transaction Date	Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
9/28/2023	Robert Michael Dudley	CEO	Buy	2,450	$20.40	$49,980.00
9/28/2023	Thomas A Fitzgerald	CFO	Buy	1,233	$20.40	$25,153.20
6/20/2023	Robert Michael Dudley	CEO	Buy	165	$102.00	$16,830.00
6/9/2023	Robert Michael Dudley	CEO	Buy	475	$110.40	$52,440.00

(Data available from 1/1/2013 forward)

RNAZ Insider Trading Activity - Frequently Asked Questions

Who is on TransCode Therapeutics's Insider Roster?: The list of insiders at TransCode Therapeutics includes Robert Michael Dudley, and Thomas A Fitzgerald. Learn more on insiders at RNAZ.
What percentage of TransCode Therapeutics stock is owned by insiders?: 1.47% of TransCode Therapeutics stock is owned by insiders. Learn more on RNAZ's insider holdings.

Which TransCode Therapeutics insiders have been buying company stock?: The following insiders have purchased RNAZ shares in the last 24 months: Robert Michael Dudley ($142,250.00), and Thomas A Fitzgerald ($25,153.20).
How much insider buying is happening at TransCode Therapeutics?: Insiders have purchased a total of 4,348 RNAZ shares in the last 24 months for a total of $167,403.20 bought.

More Insider Trading Tools from MarketBeat

Related Companies:

Insider Tracking Tools:

Insider Trading By Country:

Latest Articles:

This page (NASDAQ:RNAZ) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

TransCode Therapeutics (RNAZ) Insider Trading & Ownership

RNAZ Insider Buying and Selling by Quarter

TransCode Therapeutics Insider and Congressional Trades History

RNAZ Insider Trading Activity - Frequently Asked Questions

More Insider Trading Tools from MarketBeat

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

TransCode Therapeutics (RNAZ) Insider Trading & Ownership

TransCode Therapeutics (NASDAQ:RNAZ) Insider Buying and Selling Activity

RNAZ Insider Buying and Selling by Quarter

TransCode Therapeutics Insider and Congressional Trades History

RNAZ Insider Trading Activity - Frequently Asked Questions

More Insider Trading Tools from MarketBeat